WPD and CNS Pharmaceuticals Announce Positive Opinion of the Polish Central Ethics Committee for the WPD-201 Study and Central IRB Study Level Approval for the CNS-201 Study Feb 18, 2021 9:05am EST
CNS Pharmaceuticals to Present at the H.C. Wainwright BioConnect 2021 Conference Jan 07, 2021 8:30am EST
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent FDA Approval of IND Application Dec 28, 2020 8:00am EST
CNS Pharmaceuticals Call to Discuss FDA IND Approval and Phase 2 Trial for Berubicin Today at 8:30am ET Dec 18, 2020 8:00am EST
CNS Pharmaceuticals Announces Call to Discuss FDA IND Approval and Phase 2 Trial for Berubicin Dec 17, 2020 4:05pm EST
CNS Pharmaceuticals Announces FDA Approval of IND Application for its Brain Cancer Drug Candidate Berubicin Dec 17, 2020 9:00am EST
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent Announcements for Glioblastoma Multiforme (GBM) Therapy Nov 24, 2020 8:00am EST
CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting Nov 19, 2020 8:00am EST
